本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

18.80
-0.8800-4.47%
盤後18.800.00000.00%19:30 EDT
成交量:35.80萬
成交額:675.39萬
市值:6.98億
市盈率:-2.54
高:20.31
開:19.60
低:18.40
收:19.68
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:1.06
換手率:2.24%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:9.63
市盈率(LYR):-1.47

資料載入中...

2022/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/25

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report
2022/01/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities